Jun. 12 at 10:24 PM
Precipio (Nasdaq:
$PRPO ) to present at Planet MicroCap Las Vegas 2026 on Wednesday, June 17 at 9:00 AM PT, with CEO Ilan Danieli and COO A. Zaki Sabet hosting and taking questions.
Precipio, Inc. - Nasdaq: PRPO, a specialty cancer diagnostics company, announced it will present at the Planet MicroCap Las Vegas 2026 conference on Wednesday, June 17, 2026, at 9:00 AM local time (12:00 PM Eastern) at the Bellagio Resort & Hotel. CEO Ilan Danieli and COO Zaki Sabet will host the presentation and answer questions at its conclusion.
Precipio is a B2i Digital Featured Company. See the company’s profile at b2idigital.com/precipio-inc-1 and follow Precipio on X, LinkedIn, and Facebook.
Presentation Details:
• Date and time: Wednesday, June 17, 2026 at 9:00 AM local time (12:00 PM Eastern)
• Location: Bellagio Resort & Hotel, Las Vegas, NV
• Live webcast: https://event.summitcast.com/view/bpjo3VVjZ25pp6SXpUua92/guest_book?session_id=eBvgVV9828KPmKhWjthbta
• 1x1 investor meetings will be scheduled and conducted in person at the conference venue; registration is required at https://www.meetmax.com/sched/event_130817/conference_register.html
“As a profitable company that is looking to raise awareness rather than raise capital, this conference fits perfectly within our strategy of building our shareholder base, and getting our story out,” said Ilan Danieli, CEO of Precipio.
Ahead of the conference, MicroCapClub conducted a brief interview with Danieli, available at https://www.youtube.com/watch?v=9P56V0GZyH8
Read the full press release: https://www.precipiodx.com/precipio-to-present-at-the-planet-microcap-las-vegas/
Precipio is a healthcare biotechnology company focused on cancer diagnostics. Its mission is to address the problem of cancer misdiagnoses by developing diagnostic products and services designed to deliver greater accuracy, improved laboratory workflow, and better patient outcomes. Precipio develops, validates, and clinically uses these technologies in its laboratory before commercializing them as proprietary products for the global laboratory community.
More information is at precipiodx.com. Investor inquiries:
[email protected], +1-203-787-7888 Ext. 523.
Disclosure: This post is informational only and is not an offer or solicitation regarding any security. See the complete Disclosure at b2idigital.com/disclaimer. B2i Digital is not a broker-dealer or investment adviser.
